Research News and Research

RSS

BMI not linked with either surgical complications or esophageal cancer patient survival

Researchers at Moffitt Cancer Center in Tampa, Fla., have found - contrary to previous studies linking inferior outcomes in patients with gastrointestinal malignancies to higher body mass index (BMI) - that in their study of BMI and negative outcomes, there was no such link. They concluded that BMI was not associated with either surgical complications or esophageal cancer patient survival.

29 Mar 2012

Papillary renal cell carcinoma patients face low tumour re-occurrence and cancer-related death rates

Patients with papillary renal cell carcinoma, the second most common kidney cancer subtype, face a low risk of tumour recurrence and cancer-related death after surgery. Those are the key findings of a multi-centre study of nearly 600 patients published in the April issue of the urology journal BJUI.

29 Mar 2012

State roundup: Georgia's child-only insurance policies; N.Y. exchange impasse

The Senate's Republican majority refused to agree to create a "health exchange," or state-based health insurance market required under President Barack Obama's health care overhaul, for individuals and small businesses to insure more Americans.

29 Mar 2012

Avian and swine flu viruses hijack genetic regulators during human infection

Researchers at the University of British Columbia have identified a number of tiny but powerful "genetic regulators" that are hijacked by avian and swine flu viruses during human infection.

29 Mar 2012

Recognizing the importance of working together to make an impact on global issues

In this post in the Huffington Post's "Global Motherhood" blog, Robin Smalley, co-founder and international director of mothers2mothers, discusses how partnerships and access to a supportive network of individuals has helped mothers2mothers expand their efforts to prevent mother-to-child transmission (PMTCT) of HIV/AIDS.

29 Mar 2012

COPD Foundation to lead DRIVE4COPD campaign

The successful national campaign to increase public awareness of COPD changed organizational leadership effective March 23, 2012. Led since inception by Boehringer Ingelheim Pharmaceuticals Inc., a leader in developing medicines to treat COPD, the DRIVE4COPD campaign will now be led by the COPD Foundation, a not-for-profit organization dedicated to the education, early diagnosis, research and enhanced therapy for people with lives impacted by COPD.

29 Mar 2012

Ember adds Joslin's BMP7 technology to brown fat intellectual property portfolio

Ember Therapeutics, Inc., a company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease, today announced the completion of an agreement with the Joslin Diabetes Center to exclusively license intellectual property covering bone morphogenetic protein 7 (BMP7), which has been shown to play a role in the regulation of brown fat development.

29 Mar 2012

Court wonders which parts of law -- if any -- can stand without the mandate

In exploring the severability question, the justices will ponder whether other parts of the health law can go forward if they void the individual mandate, considered the measure's central element. News outlets examine the "contingency plans" being explored by the law's supporters in case the mandate falls.

29 Mar 2012

CRT, EIF create £50M Cancer Research Technology Pioneer Fund

Cancer Research Technology, (CRT) Cancer Research UK's commercial arm, and the European Investment Fund (EIF) have joined together to create a £50M investment fund to bridge the funding gap in the UK between cancer drug discovery and early development.

29 Mar 2012

Positive results from Nile's cenderitide Phase 1 trial on chronic heart failure

Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced results from its recently completed Phase 1 clinical trial evaluating the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of subcutaneous bolus and subcutaneous infusion of cenderitide in patients with chronic heart failure.

29 Mar 2012

Ethiopia's workplace HIV/AIDS policy aims to help employers, employees nationwide

Ethiopia's new HIV/AIDS workplace policy, instituted in January by the government in cooperation with the country's main employees' and employers' associations, "is expected to protect job seekers from mandatory HIV tests, while facilitating voluntary counseling and testing and defending the right of employees living with HIV to medical leave or job re-allocation," PlusNews reports.

29 Mar 2012

Greenwood launches Syndromic Autism 62-Gene Panel

RainDance Technologies, Inc., the Digital Biology Company, today announced that Greenwood Genetic Center has commercially launched its Syndromic Autism 62-Gene Panel which was built for use on RainDance's picodroplet-based targeted sequencing platform.

29 Mar 2012

OncoSec Medical closes sale of 31,000,000 shares of common stock in registered public offering

OncoSec Medical Incorporated, which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, announced today the closing of the sale to institutional investors of an aggregate of 31,000,000 shares of its common stock at $0.25 per share in a registered public offering.

29 Mar 2012

Daiichi Sankyo, NGM to discover and develop new treatments for diabetes

Daiichi Sankyo Company, Ltd. and NGM Biopharmaceuticals, Inc. announced today that they have entered into a research collaboration and license agreement to discover and develop novel therapeutics that modulate beta-cell regeneration for the treatment of diabetes.

29 Mar 2012

New technique could restore fertility of boys undergoing cancer treatment

Treatments for childhood cancers are increasingly successful with cure rates approaching 80%, but success often comes with a downside for the surviving men: the cancer treatments they received as boys can leave them sterile as adults. Now, a research team led by Ralph Brinster of the University of Pennsylvania School of Veterinary Medicine has completed a 14-year experiment that gives hope for a technique that could restore their fertility.

29 Mar 2012

AP examines whether health law debate is muted if Romney is GOP nominee

In other campaign news, James Carville says a loss at the Supreme Court will help Democrats politically.

29 Mar 2012

UNAIDS, NEPAD sign MoU to collaborate in efforts to fight HIV

UNAIDS and the New Partnership for Africa's Development (NEPAD) Agency on Tuesday "signed a memorandum of understanding (MoU) calling for strategic collaboration to advance sustainable responses to HIV, health and development across the African continent," according to a UNAIDS press release. "

29 Mar 2012

UTHealth, PLx Pharma to test phosphatidylcholine-enriched version of indomethacin in PDA model

PLx Pharma Inc, a Houston-based pharmaceutical company developing a medical discovery made at The University of Texas Health Science Center at Houston (UTHealth) Medical School, has been awarded $565,449 for the first year of a potential two-year $1,118,398 grant to conduct research designed to enhance a treatment for premature babies with a common congenital heart defect.

29 Mar 2012

Obstacles standing in the way of cancer prevention

More than half of all cancer is preventable, and society has the knowledge to act on this information today, according to Washington University public health researchers at the Siteman Cancer Center in St. Louis.

29 Mar 2012

BioSeek, Merck Serono sign new BioMAP collaboration agreement

BioSeek, LLC, a subsidiary of Asterand plc, a pioneer in the application of predictive human biology to drug discovery, announced today that it has signed a new, three-year collaboration agreement with Merck Serono, a division of Merck KGaA, Darmstadt, Germany.

29 Mar 2012

Research News and Research

BMI not linked with either surgical complications or esophageal cancer patient survival

Papillary renal cell carcinoma patients face low tumour re-occurrence and cancer-related death rates

State roundup: Georgia's child-only insurance policies; N.Y. exchange impasse

Avian and swine flu viruses hijack genetic regulators during human infection

Recognizing the importance of working together to make an impact on global issues

COPD Foundation to lead DRIVE4COPD campaign

Ember adds Joslin's BMP7 technology to brown fat intellectual property portfolio

Court wonders which parts of law -- if any -- can stand without the mandate

CRT, EIF create £50M Cancer Research Technology Pioneer Fund

Positive results from Nile's cenderitide Phase 1 trial on chronic heart failure

Ethiopia's workplace HIV/AIDS policy aims to help employers, employees nationwide

Greenwood launches Syndromic Autism 62-Gene Panel

OncoSec Medical closes sale of 31,000,000 shares of common stock in registered public offering

Daiichi Sankyo, NGM to discover and develop new treatments for diabetes

New technique could restore fertility of boys undergoing cancer treatment

AP examines whether health law debate is muted if Romney is GOP nominee

UNAIDS, NEPAD sign MoU to collaborate in efforts to fight HIV

UTHealth, PLx Pharma to test phosphatidylcholine-enriched version of indomethacin in PDA model

Obstacles standing in the way of cancer prevention

BioSeek, Merck Serono sign new BioMAP collaboration agreement

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery